Efficacy and Safety Study of OncoVEXGM-CSF Compared to GM-CSF in Melanoma

This study is ongoing, but not recruiting participants.
Sponsor:
Collaborator:
Amgen Research (Munich) GmbH
Information provided by (Responsible Party):
BioVex Limited
ClinicalTrials.gov Identifier:
NCT00769704
First received: October 7, 2008
Last updated: June 1, 2012
Last verified: June 2012
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is ongoing, but not recruiting participants.
  Estimated Study Completion Date: September 2014
  Estimated Primary Completion Date: January 2013 (Final data collection date for primary outcome measure)